rom currently available data, almost all cancer patients are at higher risk of COVID-19
mortality, and older people (men more than women) appear to be at higher risk of
mortality than younger people. Thus, efforts to reduce the risk of exposure of COVID-19
patients are needed, for example with reduction in the frequency of follow-up visits and
in-person visits with telephone or remote telemedicine (Skype, Zoom, Liyfe
are some free ones) follow-up.
All asymptomatic routine follow-up patients may be rescheduled for three months or
majority of patients who have recently completed chemo therapy or radiotherapy can
follow-up extended by two to three months or more, with telemedicine as needed.
There are published data on nurse-led telephone follow-up and virtual PSA monitoring
prostate cancer patients can be monitored remotely unless symptomatic or with concerns
A small study randomizing lung cancer patients to symptom-based follow-up versus routine
found a survival benefit favoring symptom-based strategy. Whether telephone follow-ups
substitute in the short term for in-person visits is unknown.